Evaluation of Bayesian Linear Regression models for gene set prioritization in complex diseases.

Area of Science:

• Genetics and Bioinformatics
• Complex Trait Analysis
• Statistical Genomics

Background:

• Genome-wide association studies (GWAS) identify genetic variants for complex traits but face challenges in interpreting polygenic results.
• Gene set analysis aggregates variants into pathways, improving the detection of coordinated genetic effects across multiple genes.
• Existing methods require robust approaches for prioritizing biologically relevant pathways from complex genetic data.

Purpose of the Study:

• To present and evaluate a novel gene set prioritization approach using Bayesian Linear Regression (BLR) models.
• To uncover shared genetic components among different phenotypes and enhance biological interpretation of GWAS findings.
• To compare the performance of BLR against established methods like MAGMA, particularly for highly overlapped gene sets.

Main Methods:

• Developed and applied Bayesian Linear Regression (BLR) models for gene set prioritization.
• Conducted extensive simulations to assess model performance under various genetic architectures and trait parameters.
• Applied single-trait and multi-trait BLR models to GWAS summary data for type 2 diabetes (T2D) and related phenotypes.

Main Results:

• BLR models demonstrated efficacy in prioritizing pathways for complex traits, outperforming MAGMA, especially with highly overlapped gene sets.
• Multi-trait BLR analysis significantly improved the identification of T2D-related pathways compared to single-trait analyses, showing increased statistical power.
• Enrichment analysis confirmed significant enrichment of diabetes-related genes within pathways identified by the multi-trait BLR approach.

Conclusions:

• The BLR model offers a flexible and powerful framework for gene set prioritization, handling diverse genomic features and integrating multi-trait information.
• Multi-trait BLR analysis enhances the discovery of genetic underpinnings for complex diseases like T2D, advancing biological interpretation.
• This approach holds potential for personalized medicine by improving our understanding of the genetic architecture of multifactorial traits.